Delivery Order SPE2DR25D3201-SPE2DR26FT5YX
- Not listed
- This is a $1,877.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Toviaz ER 4 mg tablets, a medication used to treat overactive bladder. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $3,435.93. The contract is for the delivery of Toviaz ER 8 MG Tablets, a medication used to treat overactive bladder. The contract has a firm fixed price and the ultimate completion date is February 15, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,254.09, is for the supply of Toviaz ER 8 MG Tablet 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.25 firm fixed-price delivery order is for the supply of Toviaz ER 8 mg tablets, a prescription medication, to support military healthcare programs. The contract has a performance period through May 5, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Toviaz ER tablets. The order is valued at $3,036.13 and has a performance period through August 2024. The contract is a firm-fixed-price delivery order without any set-aside designation. AmerisourceBergen has been awarded multiple indefinite-delivery contracts (IDCs) by the DLA and other federal agencies, such as the Department of...
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,064.32, is for the delivery of the medication Toviaz ER 4 mg tablets to support military healthcare programs. The contract has a completion date of November 14, 2024 and is a firm fixed-price contract. There is no set-aside designation noted for this award. AmerisourceBergen...
- This federal contract award, with ID SPE2DB22D2218|SPE2DB25FR2HY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Toviaz ER 8 mg tablets. The contract has a firm fixed price, a ceiling value of $1,203.84, and an ultimate completion date of April 16, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $3,402.42 to supply 4562704062 TOVIAZ ER 4 MG TABLET 30S. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 6, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $2,724.21, is for the delivery of TOVIAZ ER 8 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance extending through May 28, 2025. This award is not associated with a set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,425.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TOVIAZ ER 4 MG TABLET 30S. This award is part of a larger DLA Troop Support Medical program to supply pharmaceuticals and medical supplies to military treatment facilities. AmerisourceBergen, a prime contractor, has previously received numerous delivery orders from DLA for a range of pharmaceutical and medical...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5YXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,741.77 to AmerisourceBergen Drug Corp for the supply of Toviaz ER 8 mg tablets (30-count) on January 28, 2026, with completion anticipated by January 29, 2026. This firm fixed-price contract is non-set-aside and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. Toviaz is a prescription medication used to treat overactive bladder, representing one of many pharmaceutical products AmerisourceBergen supplies to support federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical prime vendor contract extended through December 31, 2031. The IDC serves as a global supply vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, medical devices, and other critical healthcare commodities to military treatment facilities and federal healthcare programs worldwide. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to efficiently fulfill government pharmaceutical procurement requirements through competitive, firm fixed-price delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/27/26 |